We serve Chemical Name:2-Benzyl-2,8-diazaspiro[4.5]decane CAS:867009-61-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-Benzyl-2,8-diazaspiro[4.5]decane](https://a.dearchem.com/CAS2/867009-61-8.png)
Chemical Name:2-Benzyl-2,8-diazaspiro[4.5]decane
CAS.NO:867009-61-8
Synonyms:2,8-Diazaspiro[4.5]decane, 2-(phenylmethyl)-;2-(Phenylmethyl)-2,8-diazaspiro[4.5]decane;2-Benzyl-2,8-diazaspiro[4.5]decane
Molecular Formula:C15H22N2
Molecular Weight:230.349
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:340.8±35.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.584
PSA:15.27000
Exact Mass:230.178299
LogP:2.15
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,8-Diazaspiro[4.5]decane, 2-(phenylmethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzyl-2,8-diazaspiro[4.5]decane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,8-Diazaspiro[4.5]decane, 2-(phenylmethyl)- Use and application,2-(Phenylmethyl)-2,8-diazaspiro[4.5]decane technical grade,usp/ep/jp grade.
Related News: FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. 2-Benzyl-2,8-diazaspiro[4.5]decane manufacturer The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 2-Benzyl-2,8-diazaspiro[4.5]decane supplier The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 2-Benzyl-2,8-diazaspiro[4.5]decane vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 2-Benzyl-2,8-diazaspiro[4.5]decane factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 2-Benzyl-2,8-diazaspiro[4.5]decane factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.
